C4 Therapeutics Inc (NASDAQ:CCCC) price is hovering higher on Wednesday, May 08, jumping 1.91% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $6.79. Taking into account the 52-week price action we note that the stock hit a 52-week high of $11.88 and 52-week low of $1.06. The stock subtracted -13.17% on its value in the past month.
The average estimate suggests sales growth for the quarter will likely rise by 57.30% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of 26.83M for the company’s annual revenue in current year. Per this projection, the revenue is forecast to grow 29.30% above that which the company brought in the current year earning report.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give CCCC a short term outlook of Hold on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that CCCC’s price is at present 2.08% off the SMA20 and -16.05% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 47.33, with weekly volatility standing at 6.14%. The indicator jumps to 5.68% when calculated based on the past 30 days. C4 Therapeutics Inc (NASDAQ:CCCC)’s beta value is holding at 3.23, while the average true range (ATR) indicator is currently reading 0.43.
An analysis of the C4 Therapeutics Inc (NASDAQ:CCCC) stock in terms of its daily trading volume indicates that the 3-month average is 2.24 million.
Current records show that the company has 60.47M in outstanding shares. The insiders’ percentage holdings are 15.88% of outstanding shares while the percentage share held by institutions stands at 71.65%. But the 22.48% upside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
